US Patent

US9314475 — Oral and injectable formulations of tetracycline compounds

Formulation · Assigned to Paratek Pharmaceuticals Inc · Expires 2031-03-18 · 5y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects oral and injectable formulations of tetracycline compounds, including a specific oral formulation of a 9-aminomethyl tetracycline compound in tablet or capsule form.

USPTO Abstract

Injectable and oral formulations of a tetracycline compound are described. In one embodiment, the invention pertains to an oral formulation of a 9-aminomethyl tetracycline compound, or a salt thereof, in tablet form or capsule. The formulations may be used, for example, to treat infections.

Drugs covered by this patent

Patent Metadata

Patent number
US9314475
Jurisdiction
US
Classification
Formulation
Expires
2031-03-18
Drug substance claim
No
Drug product claim
Yes
Assignee
Paratek Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.